INTRODUCTION
MicroRNAs (miRNAs) are small RNA molecules that posttranscriptionally repress gene expression by interacting with messenger RNAs (mRNAs). miRNAs associate with the miRNAinduced silencing complex (miRISC), the core of which is composed of an miRNA-specific Argonaute protein (Ago) and its binding partner GW182 (or AIN-1/2 in C. elegans) (Eulalio et al., 2008a) . This miRNA-ribonucleoprotein complex (miRNP) recognizes target mRNAs through sequence complementarity between the miRNA and elements in the 3 0 untranslated region (UTR) of the target mRNA. Disruption of the Ago:GW182 complex (by mutation or RNAi-mediated depletion of either component) prevents the miRNA-mediated regulation of target mRNAs (Ding et al., 2005; Eulalio et al., 2008b; Liu et al., 2005; Rehwinkel et al., 2005) . Although computational algorithms can identify many potential mRNA targets of a particular miRNA, the precise mechanism(s) and the potency of repression of specific targets likely depend on a variety of determinants. These could include additional cis-regulatory information in the target mRNA sequences and interactions of other proteins with the mRNA or miRISC.
miRISC has been shown to control gene expression by affecting at least two aspects of mRNA activity, including the translational efficiency of the mRNA and/or its stability (for reviews, see Eulalio et al., 2008a; Hammell, 2008) . Analysis of in vivo miRISC complexes indicates that the repression of miRNA-targeted transcripts involves the physical association of Argonaute proteins with a variety of cellular components, including translational initiation and mRNA turnover machinery (Behm-Ansmant et al., 2006; Chu and Rana, 2006; Eulalio et al., 2007; Mathonnet et al., 2007; Rehwinkel et al., 2005; Wang et al., 2006) . Current evidence suggests that miRISC represses protein production from miRNA targets by inhibiting (or competing with) components required for translational initiation, by reducing the efficiency of translational elongation, and/or by the miRNA-mediated turnover of target transcripts. However, current models do not adequately account for the facts (1) that some miRNA targets appear to be regulated primarily at a translational level while others are regulated by mRNA turnover or (2) that a particular miRNA can have dramatically different potencies on distinct miRNA target reporters (Eulalio et al., 2007) . Therefore, it is likely that additional proteins can interact with miRISC to modulate the nature and efficacy of miRISC activity.
Apparent negative modulators of miRISC activity include FXR and HuR, which can interact with miRNA:target complexes and dramatically overcome miRNA-mediated repression (Bhattacharyya et al., 2006; Vasudevan et al., 2007) . Knoblich and colleagues have identified members of the Drosophila TRIM-NHL and NHL-only families of proteins (Mei-P26, Brat, and Dappled) as miRISC-associated factors and have shown that Mei-P26 can function, directly or indirectly, in the negative regulation of miRNA biogenesis in Drosophila ovaries (Neumuller et al., 2008) . mei-P26 phenotypes include elevated levels of miRNAs and also reduced growth and proliferation of ovarian stem cells (Neumuller et al., 2008) . However, it is not known whether the Mei-P26 stem cell phenotypes are a direct consequence of the inappropriate repression of particular miRNA targets.
miRISC-associated factors that positively effect miRNA-mediated target repression include factors that also associate with P-bodies. P-bodies are cytoplasmic domains that contain a variety of important ribonucleoprotein complexes and can serve as sites of translational repression, decapping-mediated mRNA decay, and nonsense-mediated decay (Parker and Sheth, 2007) . Cell culture studies indicate that a key component of P-bodies, the conserved DEAD-box protein RCK/Me31B/Dhh1/CGH-1, is required for miRISC activity (Chu and Rana, 2006; Eulalio et al., 2007) . Results from multiple systems indicate that CGH-1 or its homologs can function in various processes of mRNA metabolism, including translational regulation, and mRNA turnover or stabilization (Rajyaguru and Parker, 2008) . Genetic analysis indicates that the C. elegans CGH-1 functions in the germline to stabilize certain maternal transcripts (Boag et al., 2008) . No miRNA-related phenotypes could be ascribed to CGH-1 in the worm germline, but the question remains whether CGH-1 might contribute to miRISC function during development of the somatic tissues of C. elegans.
In this manuscript we show that C. elegans NHL-2, the closest worm homolog of Drosophila Mei-P26, is an miRISC cofactor that functions together with CGH-1 in somatic cells of developing larvae to facilitate the posttranscriptional regulation of certain miRNA targets. In contrast to the effects of mei-P26 on miRNA biogenesis in fly ovaries, removal of C. elegans nhl-2 activity does not affect miRNA abundance but rather impairs the potency with which certain miRNAs repress their target mRNAs. We show that the P-body component CGH-1 interacts with NHL-2 in yeast two-hybrid assays, and that CGH-1 and NHL-2 coimmunoprecipitate from worm extracts. Furthermore, both proteins physically and functionally interact with core miRISC components. Depletion of CGH-1 or NHL-2 results in similar post-embryonic developmental phenotypes, suggesting that these proteins work together, likely in association with miRISC, to contribute to the repression of specific miRNA targets. Our results suggest a general role for TRIM-NHL proteins and CGH-1 in modulating the efficacy of miRNA:target interactions in vivo. These, and perhaps other, miRISC cofactors could function to couple miRNA activity to developmental and physiological signals and thereby help ensure the robustness of genetic pathways that involve miRNAs.
RESULTS

nhl-2 Functions in Heterochronic Gene Regulation
Postembryonic development in C. elegans proceeds through four larval stages, accompanied by a robustly controlled temporal and spatial pattern of cell division and differentiation (Sulston and Horvitz, 1977) . The heterochronic genes encode components of regulatory pathways that organize the timing of events in specific cell lineages throughout the developing larva. The heterochronic gene lin-41 encodes a member of an evolutionarily conserved family of TRIM-NHL proteins, which contain both TRIM (tripartite-containing motif; RING, B-box, coiled-coil) and NHL domains (Slack and Ruvkun, 1998) . lin-41 loss-offunction (lf) mutations cause partially penetrant phenotypes, wherein animals precociously execute adult-specific fates one stage earlier than normal (Slack et al., 2000) . phenotypes are only partially penetrant, we tested whether lin-41 may function redundantly with any of the other three members of the C. elegans TRIM-NHL gene family (nhl-1, nhl-2, and nhl-3) . We observed that removal of nhl-1, nhl-2, or nhl-3 did not enhance the lin-41 precocious phenotypes, indicating that these genes do not function redundantly with lin-41. Quite the contrary; an nhl-2 loss-of-function mutation suppressed the precocious heterochronic phenotypes caused by a hypomorphic lin-41 allele, lin-41(ma104) ( Table 1 ), suggesting that nhl-2 contributes to the normal regulation of C. elegans developmental timing, but in a manner opposite to lin-41. Depletion of the other C. elegans NHL family members by RNAi did not result in a similar suppression of lin-41(ma104) phenotypes (data not shown).
The ok818 mutation deletes 1496 bp of the nhl-2 locus, truncating the NHL-2 open reading frame, and is a presumptive null allele (nhl-2(0)) (Figures 1 and S1 available online). Approximately 3% of nhl-2(0) animals exhibit a retarded heterochronic phenotype; they fail to produce continuous adult-specific cuticular structures (alae) at the L4 molt (Table 1) , and individual seam cells reiterate L2-specific seam cell lineage patterns at the L3 stage. The relatively weak penetrance of the heterochronic phenotype of nhl-2(0) mutants does not reflect a redundancy of NHL-2 with other TRIM-NHL (NHL-1, NHL-3) or NHL-only (NCL-1) proteins, as nhl-3; nhl-2 ncl-1 nhl-1 quadruply mutant animals display an adult alae phenotype identical to singly mutant nhl-2(0) animals (Table 1) .
nhl-2 Functions with let-7 Family miRNAs to Control the Timing of Stage-Specific Hypodermal Cell Fates The low penetrance of the nhl-2(0) retarded phenotypes is reminiscent of the defects associated with certain mutants of the let-7 family miRNA genes. The let-7 family miRNAs mir-48, mir-241, and mir-84 are required to negatively regulate HBL-1 expression during the L2-L3 transition of larval development by binding complementary elements in the 3 0 UTR of hbl-1 transcripts (Abbott et al., 2005) . These miRNAs function redundantly; the retarded phenotypes of animals lacking all three let-7 family miRNAs are highly penetrant, while the defects of singly mutant mir-48(0), mir-241(0), or mir-84(0) animals are weak (Abbott et al., 2005) . The retarded phenotypes of animals singly mutant for individual let-7 family miRNAs are dramatically enhanced in combination with an nhl-2(0) mutation (Table 1 ). This enhancement is apparent in three independent assays for stage-specific hypodermal cell fates: (1) the spatio-temporal expression of an adult-specific GFP-reporter (col-19::GFP), (2) the timing of L2-specific seam cell division programs, and (3) the production of adult-specific alae (Figure 1 , Tables 1 and S1). nhl-2(0) mutations also enhance the retarded phenotypes associated with a hypomorphic allele of let-7, let-7(mg279) (Figure 1E ). RNAi depletion of hbl-1 completely suppressed the heterochronic defects associated with nhl-2(0); let-7 family miRNA compound mutants (Table S1 ). These results indicate that nhl-2 functions with or in parallel to the let-7 family miRNAs to repress HBL-1 during normal development.
nhl-2 Is Required for mir-48 Overexpression Phenotypes mir-48(ve33) is a mutation in the mir-48 promoter that causes overexpression of miR-48 and consequently an abnormally early downregulation of the miR-48 target hbl-1, which results in precocious heterochronic phenotypes (Li et al., 2005) . Animals carrying a transgenic array expressing the mir-48(ve33) mutant locus (veIs48) precociously execute L3-specific vulval divisions at the L2 molt and precociously produce adult alae at the L3 molt ( Figures 1F and 1G ). We reasoned that if nhl-2 promotes the function of let-7 family miRNAs, then nhl-2 could be required for the precocious phenotypes associated with miR-48 overexpression. Consistent with this hypothesis, nhl-2(0) suppressed all heterochronic phenotypes associated with mir-48(ve33) (Figures 1F and 1G ). Loss of nhl-2 did not affect the levels of mature miR-48, miR-84, or other let-7 family miRNAs, suggesting that nhl-2(0) suppresses mir-48(gf) and mir-84(gf) phenotypes by reducing the activity, rather than the amount, of mature let-7 family miRNAs ( Figure 1H ).
nhl-2 Functionally Interacts with Genes Encoding Core miRISC Components
Mutations in alg-1 (encoding one of the two C. elegans miRNAspecific Argonautes) or ain-1 (encoding one of two C. elegans GW182 homologs) result in pleiotropic phenotypes (Ding et al., 2005; Grishok et al., 2001; Zhang et al., 2007) , presumably reflecting the roles of alg-1 and ain-1 (together with their respective paralogs, alg-2 and ain-2) in the activity of all C. elegans miRNAs. The phenotypes of alg-1 and ain-1 mutants include developmental timing defects consistent with reduced activity of let-7 family miRNAs (Ding et al., 2005; Zhang et al., 2007) . To further test the hypothesis that nhl-2 functions in miRNA pathways, we tested whether nhl-2 mutations could enhance phenotypes associated with alg-1(lf) or ain-1(lf) mutations. nhl-2(0); alg-1(0) or nhl-2(0); ain-1(lf) animals display strong synthetic heterochronic phenotypes that include defects in adult-specific cuticle production (alae) ( Figure 1 and Table 1) . nhl-2(0); ain-1(lf) animals also reiterate L2-specific programs (seam cell overproliferation) at the L3 stage (Figure 1 ). Finally, more than 60% of nhl-2(0); ain-1(lf) animals burst from the vulval opening after the L4 molt (n > 100), a phenotype characteristic of let-7 family miRNA mutants (Abbott et al., 2005) . Thus, nhl-2 loss of function strongly enhanced the heterochronic phenotypes of alg-1 and ain-1 mutations.
Two lines of evidence suggest that loss of nhl-2 function enhances the heterochronic phenotypes of ain-1(lf) single mutants by reducing the activity of the let-7 familiy of miRNAs. First, nhl-2(0) ain-1(RNAi) animals fail to properly downregulate the expression of a hbl-1::GFP 3 0 UTR reporter by the end of the third larval stage ( Figure 1J ). Second, the col-19::GFP underexpression phenotypes, adult alae defects, and vulval bursting phenotypes associated with nhl-2(0); ain-1(lf) mutations are suppressed by hbl-1 RNAi (Table S1 ).
nhl-2 Facilitates the Negative Regulation of the let-7
Family Target let-60 during Vulval Development We hypothesized that nhl-2 activity could function more broadly with let-7 family miRNAs and play a role in the regulation of let-7 family targets other than hbl-1. Accordingly, we tested if nhl-2 activity was required for the proper regulation of another known let-7 family miRNA target, let-60/RAS (Johnson et al., 2005) . let-60/RAS plays an essential role in vulval development where it initiates a cascade of gene expression resulting in the specification of vulval tissues (Beitel et al., 1990; Han et al., 1990) . Vulva precursor cell (VPC) fate is sensitive to the dosage of let-60 activity. let-60(gf) alleles result in elevated LET-60 activity and cause ectopic specification of fates in VPCs that would otherwise adopt nonvulval cell fates (Beitel et al., 1990; Han et al., 1990) . For example, let-60(n1046gf) is semidominant and causes ectopic vulval induction (Muv) in 2% of heterozygous let-60(n1046)/+ animals (Table S2 and Figure 2 ). We used let-60(n1046)/+ as a sensitized genetic background to test for a role for nhl-2 in the regulation of let-60 by mir-84. nhl-2(0); let-60(n1046)/+ animals displayed an enhanced Muv phenotype compared to let-60(n1046)/+ alone (Figures 2B-2E and Table  S3 ). A temperature-sensitive let-60(gf) allele, let-60(ga89ts), was also enhanced by an nhl-2 mutation at the restrictive temperature ( Figure 2F and Table S3 ). Overexpression of mir-84 has been shown to partially suppress the Muv phenotypes associated with let-60(gf) alleles ( Figure 2F , Table S3 ) (Johnson et al., 2005) . Consistent with nhl-2 functioning to promote the activity of let-7 family miRNAs, removal of nhl-2 significantly reduces the suppressive effect of mir-84 overexpression ( Figure 2F and Table  S3 ). Together, these results indicate that nhl-2 functions in the regulation of at least two let-7 family miRNA targets and suggest that nhl-2 may function in miRISC activity.
nhl-2 Is Required for the Efficient Posttranscriptional Regulation of cog-1 by the lsy-6 miRNA To test the hypothesis that nhl-2 may function with miRNAs other than let-7 family miRNAs, we tested for effects of nhl-2 mutations on the activity of an unrelated C. elegans miRNA, lsy-6. lsy-6 functions in the specification and differential gene expression of two morphologically similar and bilaterally symmetric neurons, ASEL and ASER (Johnston and Hobert, 2003) . A major determinant distinguishing these two neurons is the ASEL-specific expression of the lsy-6 miRNA and the resulting downregulation of a key lsy-6 target, the transcription factor COG-1 (Johnston and Hobert, 2003) . Animals lacking lsy-6 expression fail to downregulate COG-1 in ASEL neurons. As a consequence, the ASEL neurons of lsy-6 null animals (lsy-6(ot71)) adopt the ASER fate due to derepression of COG-1 (Figures 3A and 3B) .
We tested whether nhl-2 functions in the lsy-6 pathway by assaying whether nhl-2(0) mutations could enhance the weak phenotypes associated with lsy-6(ot150), a hypomorphic allele of lsy-6 (corresponding to mutation of a putative ASE promoter element). lsy-6(ot150) animals display a partially penetrant ASEL fate specification phenotype, presumably due to underaccumulation of lsy-6 miRNA (Sarin et al., 2007) (Figure 3B ). The ASEL fate was assayed by scoring for expression of a lim-6 pro ::GFP reporter that is specifically expressed in ASEL and whose expression in this neuron is normally maintained by lsy-6. Removal of nhl-2 activity dramatically enhanced the ASEL fate specification phenotypes associated with lsy-6 (ot150) ( Figure 3B ). These results indicate that NHL-2 functions as a cofactor with lsy-6 miRNA. Consistent with such a modulatory role, nhl-2(0) mutations did not affect ASEL fate specification in an otherwise wild-type genetic background, indicating that NHL-2 is not strictly essential for lsy-6 miRNA activity ( Figure 3B ).
In addition to the role that cog-1 plays in ASEL/R neuronal specification, cog-1 also functions in tissues that do not normally express lsy-6 miRNA, including the vulva and uterus (Palmer et al., 2002) . Ectopic expression of lsy-6 from the cog-1 promoter results in the downregulation of COG-1 in vulval and uterine tissues (Johnston and Hobert, 2003) . We reasoned that if nhl-2 functions with lsy-6 to repress cog-1 expression, removing nhl-2 activity should reduce the repression that ectopic lsy-6 expression exerts on a COG-1::GFP reporter. Consistent with this hypothesis, COG-1::GFP expression was partially restored in vulval, uterine, and ASER neurons of animals expressing cog-1 pro ::lsy-6 and lacking nhl-2 ( Figures 3C and 3D and data not shown). Removal of nhl-2 activity did not affect vulval or uterine expression of COG-1::GFP in animals lacking ectopically expressed lsy-6, indicating that nhl-2 is not involved in lsy-6-independent regulation of cog-1.
NHL-2 Physically Interacts with the DEAD-Box Protein CGH-1 and Localizes to Cytoplasmic Processing Bodies
To understand how NHL-2 functions to promote miRNA activity we sought to identify proteins that interact with NHL-2. We performed a yeast two-hybrid screen with a full-length NHL-2-GAL4(BDB) fusion as bait. Among the clones that strongly interact with NHL-2-GAL4(BDB) were several GAL4-AD-CGH-1 fusions ( Figures 4B and 4C) . In parallel experiments, LC-MS/ MS analysis of material immunoprecipitated with CGH-1 antisera identified NHL-2 as a candidate polypeptide that copurified with CGH-1 complexes isolated from C. elegans lysates (see Supplemental Results). The interaction between CGH-1 and NHL-2 was unexpected because no miRNA-related phenotypes had been associated with cgh-1 mutations. The presumptively null cgh-1 mutant (cgh-1(ok492)) develops to adulthood but is . This L2-specific duplicative sterile and produces abnormal oocytes and sperm (Boag et al., 2005; Navarro et al., 2001) . CGH-1 is expressed primarily in the germline and early embryo but is also detectable in somatic P-bodies (Boag et al., 2008) . We investigated whether NHL-2 is also detectable in somatic P-bodies by examining expression of transgenes encoding NHL-2 or CGH-1 fused to fluorescent reporter proteins. In most somatic tissues, CGH-1::GFP was distributed diffusely throughout the cytoplasm and was also concentrated in punctate cytoplasmic foci that presumably represent P-bodies ( Figures 4A  and S3 ). This fluorescence pattern was also evident for GFP::NHL-2 ( Figure 4A ). Importantly, in animals coexpressing dsRED::NHL-2 and CGH-1::GFP, dsRED and GFP fluorescence was observed in overlapping diffuse and punctate patterns in the cytoplasm of neuronal and hypodermal cells ( Figure 4D and data not shown). We addressed the P-body localization of these components further by coexpressing dsRED::NHL-2 with a GFP-tagged translational fusion of DCAP-1, a diagnostic P-body component (Ding et al., 2005) . Both proteins were predominantly distributed in coincident cytoplasmic foci ( Figure 4E ), indicating that NHL-2 likely associates with CGH-1 in P-bodies of somatic cells in vivo.
cgh-1 Functions in the Heterochronic Pathway
If NHL-2 and CGH-1 function together in a complex, one would expect that mutation of either gene would have similar phenotypic consequences. cgh-1(0) homozygotes (derived from heterozygous mothers) exhibit mild heterochronic phenotypes that were not detected previously (Table 1 and data not shown). Removal of cgh-1 function dramatically enhanced the retarded heterochronic phenotypes associated with mir-48 and mir-84 loss-of-function mutations. As was observed for nhl-2(0); let-7 family compound mutants, hypodermal seam cell lineages of cgh-1(0); mir-48(0); mir-84(0) animals exhibit enhanced heterochronic developmental defects, including reiteration of L2-specific proliferative divisions during the L3 stage, and defects in adult-specific gene expression (col-19::GFP) ( Table 1, Figures  5A-5C ). These heterochronic defects also cause cgh-1(0); mir-48(0); mir-84(0) animals to burst from the vulva at the L4/ adult transition, a phenotype associated with reduced let-7 family activity. cgh-1(0) mutations strongly enhance heterochronic phenotypes associated with reduced activities of the core miRNA machinery (Table 1 ). The seam cell lineage defects, adult alae, vulval bursting, and col-19::GFP underexpression phenotypes displayed by cgh-1(0); mir-48(0); mir-84(0) animals are suppressed by hbl-1 RNAi ( Figure 5C and Table S2 ), indicating that CGH-1 is required, along with let-7 family miRNAs, for the proper downregulation of HBL-1.
nhl-2 and cgh-1 Function in Concert to Regulate the let-7 Family miRNA Target hbl-1 The above results, showing that either nhl-2(0) mutations or cgh-1(0) mutations can sensitize animals to reduction of let-7 family miRNA function ( Figures 1C-1E and 5A-5C), indicate that NHL-2 and CGH-1 may function in concert to promote let-7 family activity. Consistent with this conclusion, we found that depletion of cgh-1 activity in nhl-2(0) mutant animals results in retarded heterochronic phenotypes far more severe than nhl-2(0) or cgh-1(0) alone and results in a perdurance of hbl-1::GFP 3 0 UTR reporter in L3-staged animals (Figures 5D-5G and 5I). In addition to the enhanced heterochronic phenotypes associated with cgh-1(0) nhl-2(0) double mutants, greater than 40% of cgh-1(0) nhl-2(0) animals (derived from heterozygous mothers) die during embryogenesis or early larval development, indicating that the combined activities of nhl-2 and cgh-1 are required for viability ( Figure 5H ). This suggests that NHL-2 and CGH-1 may act together to influence the activity of additional miRNAs besides lsy-6 and let-7 family miRNAs.
NHL-2 and CGH-1 Associate with the miRISC Complex
Depletion of CGH-1 (via RNAi) does not appear to affect the biogenesis of miRNAs, nor does mutation of nhl-2 ( Figures 1H  and 6A ), suggesting that CGH-1 and NHL-2 function in step(s) after miRNA biogenesis. The yeast two-hybrid interaction between CGH-1 and NHL-2, their colocalization in P-bodies, and the genetic interactions among nhl-2, cgh-1, let-7 family miRNAs, and lsy-6 miRNA suggest that the CGH-1-NHL-2 complex may associate with components of the C. elegans miRISC. Consistent with this supposition, immunoprecipitation of the GFP::NHL-2 using anti-GFP antibodies coprecipitated seam cell division essentially doubles the number of seam cells in the hypodermis of C. elegans. In animals triply mutant for mir-48, mir-241, and mir-84, a reiteration of L2-specific seam cell division patterns occurs at the L3 stage. In contrast, animals overexpressing miR-48 skip most L2 seam cell division programs, precociously execute vulval divisions, and produce adult-specific cuticular structures at the end of the L3 stage. (B) nhl-2 encodes a member of the TRIM-NHL family of proteins, and the ok818 deletion is a null allele of nhl-2 ( Figure S1 ). components of core-miRISC machinery ( Figure 6B ). In addition, western blot analysis of complexes coimmunoprecipitated with CGH-1 indicated that CGH-1 interacts in vivo with NHL-2, and with the core-miRISC components ALG-1, ALG-2, and AIN-1 (Figure 6C) . The fraction ALG-1/2 and AIN-1 coprecipitated with GFP::NHL-2 or CGH-1 immunoprecipitation was relatively low, perhaps reflecting instability of these interactions in extracts.
The physical association of CGH-1 with the core-miRISC components is preserved in nhl-2(0) mutant animals, indicating that binding of CGH-1 to miRISC is not mediated by NHL-2 ( Figure 6D) .
Interestingly, RNase treatment of immunoprecipitated complexes dramatically reduced the association of AIN-1 and AGL-1/2 with CGH-1 but did not dissociate NHL-2 from CGH-1 ( Figure 6C ). These results are consistent with the strong interaction of CGH-1 and NHL-2 detected by yeast two-hybrid assays and furthermore suggest that in vivo CGH-1 and NHL-2 engage in a relatively strong mutual interaction, while the binding of the CGH-1-NHL-2 complex to miRISC is more indirect and depends in part on RNA:protein interactions.
DISCUSSION
nhl-2 Modulates miRNA-Mediated Regulation of CellFate Specification
In this manuscript we identify roles for nhl-2 in the miRNA-mediated posttranscriptional regulation of three key developmental control genes. The first case involves the stage-specific downregulation of the transcription factor HBL-1, which must occur properly to trigger developmental switches in cell fate that normally occur between the second and third larval stages. This downregulation of HBL-1 requires the efficient activity of the let-7 family of miRNAs, and we show here that NHL-2 contributes positively to let-7 family repression of HBL-1. Second, in C. elegans vulval development, let-7 family miRNAs contribute to the negative regulation of let-60/RAS, a critical signaling component involved in specifying certain vulval cell-fate choices. We show that NHL-2 promotes let-7 family activity in this spatial patterning of vulval cell fates. The third case involves the lsy-6 miRNA, which is required in certain neurons to confer left/right asymmetric expression of the transcription factor COG-1 and thereby to specify particular neuronal cell fates. We show that NHL-2 functions to promote lsy-6-mediated repression of COG-1 in neuronal cell-fate specification and also in other cells when lsy-6 is expressed ectopically. These results demonstrate that C. elegans NHL-2 protein is required in diverse developmental contexts to promote the robustness of cell-fate choices mediated by miRNA:target interactions.
NHL-2 Functions as a Cofactor for miRNA Activity
Our results also demonstrate that C. elegans NHL-2 (and, by implication, other TRIM-NHL family homologs) can function directly in the effector phase of miRNA-mediated posttranscriptional regulation. In support of a direct role for NHL-2 in miRISC activity are our findings that NHL-2 (1) interacts in vivo with miRISC and (2) is genetically required for the full potency of let-7 family and lsy-6 miRNA activities but (3) does not detectably affect overall miRNA levels ( Figure 6 ). We propose that nhl-2 functions as a modulatory cofactor for miRNA activity, based on our observations that (1) nhl-2 function is not essential for miRNA activity, yet (2) nhl-2 mutations enhance the loss-of-function phenotypes of particular miRNA genes (Figures 1 and 3 and Table 1 ) and (3) nhl-2 mutations suppress the gain-of-function phenotypes associated with overexpression or ectopic expression of miRNAs (Figures 1-3) . -60(ga89) . The suppression of let-60(ga89) Muv phenotypes by miR-84 is reduced in animals lacking nhl-2. Brackets indicate statistically significant differences in phenotype calculated from a two-tailed chi-square analysis from data derived from Table S3 .
Our finding that the TRIM-NHL protein NHL-2 functions positively to promote miRNA activity in C. elegans, without apparent effects on miRNA biogenesis, represents an interesting counterpoint to recent findings regarding mei-P26, the closest Drosophila homolog of nhl-2. Mutations of mei-P26 result in a variety of phenotypes that include overproliferation of undifferentiated germline tissues and alterations in neuronal development (Glasscock et al., 2005; Neumuller et al., 2008) . Molecular characterization of mei-P26 mutants indicates that, in the germline, Mei-P26 functions to repress the biogenesis of numerous miRNAs (Neumuller et al., 2008) . Neumuller et al. also report that (similar to our findings for NHL-2), Mei-P26 physically associates with the miRISC complex. Although the apparent conservation of a general TRIM-NHL:miRISC interaction is striking, in the case of Mei-P26, an indirect role in miRNA accumulation was not ruled out. Moreover, it was not possible to link the mei-P26 mutant phenotypes to the derepression or over-repression of particular miRNA targets, so those developmental defects could reflect miRNA-independent functions for Mei-P26. The apparent differences in the modes of activity of NHL-2 and Mei-P26 could also reflect different roles for these proteins in germline versus somatic tissues. In any case, our data show definitively that in somatic cells, TRIM-NHL:miRISC interactions can positively modulate miRISC activity.
A key finding from our experiments is that NHL-2 interacts physically and functionally with the P-body-associated DEADbox protein CGH-1. We observe that C. elegans NHL-2 and CGH-1 are broadly expressed in diverse cell types (both germline and somatic tissues) and hence may function in a variety of developmental processes. We show that in somatic cells, NHL-2 and CGH-1 are distributed throughout the cytoplasm and also colocalize in cytoplasmic foci. These foci correspond to P-bodies, which have been implicated in translational repression and decapping-associated mRNA turnover (Parker and Sheth, 2007) . The localization of NHL-2 and CGH-1 to P-bodies and the somatic phenotypes associated with nhl-2(0) and cgh-1(0) mutations suggest that miRNA-mediated mRNA turnover and/or translational repression may be facilitated by P-bodies. While the roles of P-bodies in miRNA-mediated repression are not yet fully understood, several structural and enzymatic components of P-bodies have also been shown to contribute to miRNA-mediated regulation (including GW182 and the decapping and mRNA turnover machinery) (Behm-Ansmant et al., 2006; Eulalio et al., 2007 Eulalio et al., , 2008b Liu et al., 2005; Rehwinkel et al., 2005) . Our finding that C. elegans CGH-1 functions to regulate HBL-1 expression in somatic cells is consistent with a conserved role for CGH-1 (and CGH-1 homologs) in miRNA-mediated gene regulation (Chu and Rana, 2006) . Previous biochemical and genetic analyses of C. elegans CGH-1 indicate that CGH-1 is localized to germline P-granules (germline-specific mRNA storage compartments) and functions in the germline to sequester and stabilize certain maternally transcribed mRNAs, possibly in association with a highly conserved family of RNAbinding proteins (Boag et al., 2005 (Boag et al., , 2008 . It is thought that, in the context of the germline, CGH-1's activity and localization to distinct mRNA storage bodies is modulated by additional factors (including germline-specific RNP components) (Rajyaguru and Parker, 2008) . A role for CGH-1 in mRNA stabilization of germline mRNAs is clearly distinct from the well-characterized role the Drosophila CGH-1 homolog (Me31B) plays in the degradation of somatic mRNAs (Eulalio et al., 2007) . Homologs of CGH-1 (Dhh1p in S. cerevisiae and RCK/54 in humans) have also been demonstrated to promote mRNA decapping and/or translational repression (Coller and Parker, 2005; Coller et al., 2001; Eulalio et al., 2007) . Our findings are consistent with numerous possible molecular models for NHL-2 activity in miRNA-mediated regulation. The essence of these models would be that NHL-2 function involves its association with miRISC and, in particular, direct binding to CGH-1. Moreover, the apparent RNase sensitivity of the interaction of the CGH-1-NHL-2 complex with miRISC indicates that CGH-1 and NHL-2 function in association with mRNA targets. The NHL-2 protein contains multiple domains ( Figure 1B) , including B-box domains, which have been implicated in RNA-binding and protein:protein interactions (Hall, 2005; Matthews and Sunde, 2002) . So, in principle, NHL-2 could interact with miRISC and target mRNAs by RNA-binding and/ or protein:protein interactions.
Models for NHL-2 activity can be broadly classified according to how NHL-2 may facilitate interactions between miRISC and miRNA targets or modulate repressive activities mediated by miRISC components. The first class of models would posit that NHL-2 associates with target mRNPs and helps stabilize the association of CGH-1-miRISC with target mRNAs and/or promote the fidelity of target recognition ( Figure 6E ). Our finding that CGH-1 remains associated with the protein components of miRISC in nhl-2(0) mutants indicates that NHL-2 does not affect CGH-1 binding to miRISC ( Figure 6D ) but does not rule out the possibility that NHL-2 could facilitate binding to targets of an miRISC:CGH-1 complex. For technical reasons, we could not examine the association of NHL-2 to miRISC in a CGH-1 null, so we cannot say whether NHL-2 binds to miRISC via CGH-1 or independently of CGH-1. Therefore, strictly speaking, our data do not distinguish whether CGH-1 and NHL-2 function interdependently, or whether each exerts distinct and independent effects on miRNA-mediated gene regulation.
In a second class of models, NHL-2 may associate with previously formed miRISC:target mRNA complexes and stimulate the repressive activity of miRISC ( Figure 6E , mode 2). In this scenario, NHL-2 would bind miRISC and stimulate the intrinsic repressive activity of one or more miRISC components (such as CGH-1) ( Figure 6E , mode 2). CGH-1 is a member of the DEAD-box family of RNA-dependant ATPases that play a variety of roles in RNA metabolism including the rearrangement of protein-protein, protein:RNA, and RNA:RNA complexes. Therefore, NHL-2 could affect multiple activities of CGH-1 or could preferentially stimulate translational inhibitory or mRNA degradative functions of CGH-1. NHL-2 could act independently of CGH-1 and simply use its physical association with miRISC to exert NHL-2-specific activities to target mRNAs, their nascent protein products, or other cellular components involved in miRNA-mediated repression ( Figure 6E ). NHL-2 and other TRIM-NHL family proteins contain RING domains, which have been implicated in the posttranslational ubiquitination of target proteins. Ubiquitination serves a variety of functions that include protein turnover, modulation, and differential subcellular localization of target proteins. In this role ( Figure 6E, mode 3) , NHL-2 may directly modify specific components of the mRNA turnover or miRISC machinery, which would in turn modulate their activity on miRNA targets. Preliminary results indicate that neither CGH-1 nor core miRISC components (ALG-1/2 and AIN-1) are significantly polyubiquitinated in vivo and the absence of NHL-2 does not lead to the mislocalization of CGH-1, ALG-1/2, or AIN-1 from somatic P-bodies ( Figure S4 and data not shown). Alternatively, NHL-2 could function as an miRISC-associated ubiquitin ligase that modifies nascent polypeptides encoded by miRNA targets or ribosomes engaged with miRISC ( Figure 6E, mode 3) .
We show that NHL-2 functions as a cofactor for let-7 family miRNAs and also for an unrelated miRNA, lsy-6. This may not represent the full range of miRISC-associated NHL-2 specificity, as nhl-2 cgh-1 doubly mutant animals display defects in somatic cell development and viability not known to be associated with reduction in let-7 family or lsy-6 miRNAs. However, our results to date do not indicate that NHL-2 functions in conjunction with all miRNAs in C. elegans, as we have not observed genetic interactions between nhl-2(0) and miRNA gene mutants other than the let-7 family and lsy-6. In sum, we propose that the modulation of miRISC activity by NHL-2 (and potentially other (E) A model representing potential roles for NHL-2 in the posttranscriptional regulation of miRNA targets. We suggest that miRISC has a basal level of repressive activity in the absence of NHL-2, leading to the reduction of protein products derived from miRNA target transcripts. Our models suggest that NHL-2 augments this basal level of activity by physically associating with miRISC. Proposed points of function and potential activities of NHL-2 include (1) an enhancement of CGH-1:miRISC:target interaction by increasing the stability or fidelity of miRNA:target interactions; (2) a stimulatory role for NHL-2 in modulating intrinsic activity of CGH-1 and/or miRISC components; and (3) a role for NHL-2 independent of CGH-1 or other known miRISC components.
TRIM-NHL proteins) functions to sharpen the posttranscriptional regulation of critical miRNA targets and may modulate miRNA efficacy in response to physiological or developmental signals and hence ensure the robustness of genetic regulatory pathways involving miRNAs.
EXPERIMENTAL PROCEDURES
Nematode Methods C. elegans strains were grown under standard conditions (Brenner, 1974) . Transformation of animals and RNAi were performed as previously described (Abbott et al., 2005; Mello et al., 1991) .
Quantification of miRNA Expression
Total RNA was isolated from either staged or mixed populations of worms and northern blots were performed as previously described (Lee and Ambros, 2001 ).
Microscopy and Phenotypic Analysis
Lineage analysis and scoring of adult alae phenotypes were performed by picking staged animals of the indicated genotypes and monitoring seam cells derived from the V lineage as described by Sulston and Horvitz (1977) .
Two-Hybrid Screening NHL-2 interacting proteins were identified using Clonetec Matchmaker according to the manufacturer's protocol. Interactions between NHL-2 and potential interacting proteins were assayed in the PJ69-4a yeast cells. GAL4-AD fusion libraries were a gift of R. Barsted.
Protein Analysis
A detailed description of lysate preparation, immunoprecipitation, and antibody protocols can be found in the Supplemental Data. A detailed description of the LC-MS/MS analysis of CGH-1 interacting proteins can be found in Supplemental Experimental Procedures.
SUPPLEMENTAL DATA
Supplemental Data include three tables, four figures, and Supplemental Experimental Procedures and can be found with this article online at http:// www.cell.com/supplemental/S0092-8674(09)00150-0.
